Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro).
| Autor: | Sang Hoon Han, Goins, Christopher M., Arya, Tarun, Woo-Jin Shin, Joshua Maw, Hooper, Alice, Sonawane, Dhiraj P., Porter, Matthew R., Bannister, Breyanne E., Crouch, Rachel D., Lindsey, A. Abigail, Lakatos, Gabriella, Martinez, Steven R., Alvarado, Joseph, Akers, Wendell S., Wang, Nancy S., Jung, Jae U., Macdonald, Jonathan D., Stauffer, Shaun R. |
|---|---|
| Zdroj: | Journal of Medicinal Chemistry; 2/24/2022, Vol. 65 Issue 4, p2880-2904, 25p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|